• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自人补体第二和第四成分的分子复合物的形成及其功能意义。

Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.

作者信息

Müller-Eberhard H J, Polley M J, Calcott M A

出版信息

J Exp Med. 1967 Feb 1;125(2):359-80. doi: 10.1084/jem.125.2.359.

DOI:10.1084/jem.125.2.359
PMID:6019133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2138355/
Abstract

A functional unit of the human complement system has been delineated. It is composed of two subunits which are derived from the second (C'2) and from the fourth (C'4) component of complement. Purified C'2 and C'4 were found to interact in free solution and to form a reversible protein-protein complex. When acted upon by C'1 esterase in the presence of Mg ions, the reversible complex acquires stability and the ability to act enzymatically on the third component of complement. The trivial name C'3 convertase has been selected to denote the enzyme. Molecular weight determinations suggest that the entire C'4 molecule, but probably only a fragment of the C'2 molecule, are incorporated into C'3 convertase. Prior treatment of C'2 with iodine led to enhanced stability and activity of the enzyme. It was shown that the cell-bound form of C'3 convertase is cytolytically active and that the free enzyme is able to induce lysis from the fluid phase of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. Evidence was presented that action of C'3 convertase on C'3 results in fragmentation of the molecule.

摘要

人类补体系统的一个功能单位已被阐明。它由两个亚基组成,这两个亚基分别来自补体的第二成分(C'2)和第四成分(C'4)。已发现纯化的C'2和C'4在自由溶液中相互作用并形成可逆的蛋白质-蛋白质复合物。当在镁离子存在下受到C'1酯酶作用时,该可逆复合物获得稳定性并具有对补体第三成分进行酶促作用的能力。已选用俗名C'3转化酶来表示该酶。分子量测定表明,整个C'4分子,但可能只有C'2分子的一个片段,被纳入C'3转化酶中。用碘预先处理C'2可提高该酶的稳定性和活性。结果表明,细胞结合形式的C'3转化酶具有溶细胞活性,而游离酶能够从阵发性夜间血红蛋白尿患者的红细胞液相中诱导细胞溶解。有证据表明,C'3转化酶对C'3的作用导致该分子断裂。

相似文献

1
Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.源自人补体第二和第四成分的分子复合物的形成及其功能意义。
J Exp Med. 1967 Feb 1;125(2):359-80. doi: 10.1084/jem.125.2.359.
2
THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION.补体成分在特异性免疫固定中的作用。
J Exp Med. 1942 Apr 1;75(4):421-35. doi: 10.1084/jem.75.4.421.
3
Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.补体作为炎症介质。3. 具有过敏毒素特性的活性物质的纯化,该活性物质由补体前四种成分相互作用产生,并鉴定为C'3的裂解产物。
J Exp Med. 1967 Dec 1;126(6):1027-48. doi: 10.1084/jem.126.6.1027.
4
The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.人补体的第二个成分:其分离、被C'1酯酶裂解以及并入C'3转化酶。
J Exp Med. 1968 Sep 1;128(3):533-51. doi: 10.1084/jem.128.3.533.
5
STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.免疫性人体溶血的研究:Ⅱ.作为研究补体作用机制和 C'1 和 C'1 酯酶作用的模型系统的唐纳特-兰德施泰纳反应。
J Exp Med. 1961 Jan 1;113(1):193-218. doi: 10.1084/jem.113.1.193.
6
[Determination of the total complement activity of serum and of 4 fractions: C'1, C'2, C'3, C'4].[血清总补体活性及4个组分(C'1、C'2、C'3、C'4)的测定]
Rev Fr Etud Clin Biol. 1967 Dec;12(10):1024-8.
7
[Determination of the fractions of complement (C'1, C'2, C'3, C'4) in hypocomplimentary glomerulopathies].[低补体性肾小球病中补体各成分(C'1、C'2、C'3、C'4)分数的测定]
Rev Fr Etud Clin Biol. 1967 Dec;12(10):990-5.
8
[Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. I. Variations in the levels of C'1, C'4, C'2 and C'3 and total complement].类风湿关节炎滑液中补体水平下降机制的研究。I. C'1、C'4、C'2和C'3水平及总补体的变化
Pathol Biol (Paris). 1970 Nov;18(21):959-67.
9
Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.补体依赖性免疫吞噬作用。I. 对C'1、C'4、C'2、C'3的需求
Exp Cell Res. 1968 Jul;51(1):45-67. doi: 10.1016/0014-4827(68)90158-4.
10
FUNCTION OF COMPONENTS OF COMPLEMENT IN IMMUNE HEMOLYSIS.补体成分在免疫溶血中的功能。
J Exp Med. 1942 Jul 1;76(1):93-101. doi: 10.1084/jem.76.1.93.

引用本文的文献

1
Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against .促进抗荚膜抗体之间的 Fc-Fc 相互作用可提供针对 的强大免疫保护。
Elife. 2023 Mar 22;12:e80669. doi: 10.7554/eLife.80669.
2
Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses.补体蛋白作为可溶性模式识别受体对致病病毒的作用。
Viruses. 2021 May 2;13(5):824. doi: 10.3390/v13050824.
3
Novel Monoclonal Antibodies Against Mouse C1q: Characterisation and Development of a Quantitative ELISA for Mouse C1q.新型抗小鼠 C1q 单克隆抗体:小鼠 C1q 的定量 ELISA 的建立和特性分析。
Mol Neurobiol. 2021 Sep;58(9):4323-4336. doi: 10.1007/s12035-021-02419-5. Epub 2021 May 18.
4
Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies.纳米抗体为补体级联反应的分子机制提供了新的见解,并为新的治疗策略提供了思路。
Biomolecules. 2021 Feb 17;11(2):298. doi: 10.3390/biom11020298.
5
Regulation of anti-microbial autophagy by factors of the complement system.补体系统因子对抗微生物自噬的调节作用。
Microb Cell. 2020 Mar 19;7(4):93-105. doi: 10.15698/mic2020.04.712.
6
Complement System in Brain Architecture and Neurodevelopmental Disorders.大脑结构与神经发育障碍中的补体系统
Front Neurosci. 2020 Feb 5;14:23. doi: 10.3389/fnins.2020.00023. eCollection 2020.
7
Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade.将 SPR 与原子力显微镜相结合,可实现对补体级联激活和抑制的单分子洞察。
J Biol Chem. 2019 Dec 27;294(52):20148-20163. doi: 10.1074/jbc.RA119.010913. Epub 2019 Nov 12.
8
iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats.基于iTRAQ的蛋白质组学分析以确定知柏地黄丸颗粒对阴虚热证大鼠作用的分子机制。
Chin Med. 2018 Jan 8;13:2. doi: 10.1186/s13020-017-0160-y. eCollection 2018.
9
Targeted Proteomics and Absolute Protein Quantification for the Construction of a Stoichiometric Host-Pathogen Surface Density Model.用于构建化学计量宿主-病原体表面密度模型的靶向蛋白质组学与绝对蛋白质定量
Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S29-S41. doi: 10.1074/mcp.M116.063966. Epub 2017 Feb 9.
10
Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.补体C2及其C4复合物的溶液结构提出了补体前转化酶控制和激活的途径特异性机制。
J Biol Chem. 2016 Aug 5;291(32):16494-507. doi: 10.1074/jbc.M116.722017. Epub 2016 Jun 1.

本文引用的文献

1
Complement and Hemolysis.补体与溶血
Science. 1963 Aug 23;141(3582):738-40. doi: 10.1126/science.141.3582.738.
2
THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT.阵发性夜间血红蛋白尿症患者红细胞被补体第三成分部分纯化亚组分的溶血作用
J Clin Invest. 1965 Sep;44(9):1534-46. doi: 10.1172/JCI105260.
3
ESTIMATION OF MOLECULAR SIZE OF COMPLEMENT COMPONENTS BY SEPHADEX CHROMATOGRAPHY.用葡聚糖凝胶色谱法估算补体成分的分子大小
J Immunol. 1965 Apr;94:510-3.
4
C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.C1酯酶对补体第四成分活性及理化性质的影响
J Exp Med. 1965 May 1;121(5):819-33. doi: 10.1084/jem.121.5.819.
5
THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.人类补体第一成分的大分子性质
J Exp Med. 1964 Apr 1;119(4):593-613. doi: 10.1084/jem.119.4.593.
6
STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.人C1酯酶的研究。I. 纯化及酶学性质
J Immunol. 1964 Mar;92:456-67.
7
ACTIVE CENTER OF CARBOXYPEPTIDASE A.羧肽酶A的活性中心。
Fed Proc. 1964 Jan-Feb;23:8-17.
8
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.人补体第四成分的分离与描述
J Exp Med. 1963 Sep 1;118(3):447-66. doi: 10.1084/jem.118.3.447.
9
C'2ad, an inactive derivative of C'2 released during decay of EAC'4,2a.C'2ad,一种在EAC'4,2a衰变过程中释放的C'2非活性衍生物。
Immunochemistry. 1966 May;3(3):163-76. doi: 10.1016/0019-2791(66)90182-0.
10
Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.正常人及阵发性睡眠性血红蛋白尿症(PNH)红细胞的免疫溶解作用。I. PNH红细胞对补体和特异性抗体介导的溶解作用的敏感性。
J Clin Invest. 1966 May;45(5):736-48. doi: 10.1172/JCI105388.